In this vein, while no general consensus has yet been reached, and the major conclusions indicate that further work is needed to firmly establish a causal link between circulating IGF-I levels and cognition [47], available information allows us to suggest that preserved brain IGF-I activity also contributes to resilience to AD pathology. This evidence concerns the gene IGF1 and Alzheimer disease.